SOPHiA GENETICS SA Q4 2025 Results Call Summary
SOPHiA GENETICS SA Q4 2025 Results Call Summary – Moby Achieved 22% total revenue growth in Q4 2025, driven by a 31% increase in clinical revenue as the core business reaccelerated toward historic levels. It will process nearly 1 petabyte of genomic data in 2025, doubling the volume from two years ago due to a…